{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T20:46:10Z","timestamp":1648932370557},"reference-count":21,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2019.9821","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T08:14:26Z","timestamp":1546589666000},"source":"Crossref","is-referenced-by-count":0,"title":["Combination leflunomide and methotrexate impedes the recovery of liver fibrosis, partly through inhibition of myeloid cell admittance"],"prefix":"10.3892","author":[{"given":"Mengxin","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, The First Hospital of Quanzhou City, Quanzhou, Fujian 362000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyi","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The First Hospital of Quanzhou City, Quanzhou, Fujian 362000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The First Hospital of Quanzhou City, Quanzhou, Fujian 362000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaopeng","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The First Hospital of Quanzhou City, Quanzhou, Fujian 362000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawu","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The First Hospital of Quanzhou City, Quanzhou, Fujian 362000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"key20200713231822_b1-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0140-6736(17)32671-5","article-title":"Chronic liver disease: Scavenger hunt for novel therapies","volume":"391","author":"Patten","year":"2018","journal-title":"Lancet"},{"key":"key20200713231822_b2-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20200713231822_b3-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: Immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"key20200713231822_b4-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1001\/archinte.160.5.610","article-title":"The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation","volume":"160","author":"Janssen","year":"2000","journal-title":"Arch Intern Med"},{"key":"key20200713231822_b5-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/ard.2003.016709","article-title":"When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?","volume":"64","author":"Dougados","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"key20200713231822_b6-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","article-title":"Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis","volume":"47","author":"Wessels","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713231822_b7-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2165\/00003088-200241060-00003","article-title":"Clinical pharmacokinetics of leflunomide","volume":"41","author":"Rozman","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"key20200713231822_b8-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"R232","DOI":"10.1186\/ar4075","article-title":"Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate","volume":"14","author":"Lee","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"key20200713231822_b9-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/ar3865","article-title":"Current treatment of hepatitis C-associated rheumatic diseases","volume":"14","author":"Ferri","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"key20200713231822_b10-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/hep.27635","article-title":"Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis","volume":"61","author":"Kantari-Mimoun","year":"2015","journal-title":"Hepatology"},{"key":"key20200713231822_b11-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"Duffield","year":"2005","journal-title":"J Clin Invest"},{"key":"key20200713231822_b12-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/jcbfm.2010.220","article-title":"Animal research: Reporting in vivo experiments-the ARRIVE guidelines","volume":"31","author":"Kilkenny","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"key20200713231822_b13-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713231822_b14-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1136\/gut.2010.207423","article-title":"Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C","volume":"59","author":"Fontana","year":"2010","journal-title":"Gut"},{"key":"key20200713231822_b15-mmr-19-03-1622","first-page":"915","article-title":"Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats","volume":"25","author":"Yao","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"key20200713231822_b16-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.lfs.2009.01.017","article-title":"Accelerative effect of leflunomide on recovery from hepatic fibrosis involves TRAIL-mediated hepatic stellate cell apoptosis","volume":"84","author":"Tang","year":"2009","journal-title":"Life Sci"},{"key":"key20200713231822_b17-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/art.1780361208","article-title":"The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis","volume":"36","author":"Bjorkman","year":"1993","journal-title":"Arthritis Rheum"},{"key":"key20200713231822_b18-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pharep.2014.08.009","article-title":"Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis","volume":"67","author":"Bilasy","year":"2015","journal-title":"Pharmacol Rep"},{"key":"key20200713231822_b19-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.4049\/jimmunol.178.4.2000","article-title":"Distinct differentiation potential of blood monocyte subsets in the lung","volume":"178","author":"Landsman","year":"2007","journal-title":"J Immunol"},{"key":"key20200713231822_b20-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1084\/jem.20070885","article-title":"The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions","volume":"204","author":"Nahrendorf","year":"2007","journal-title":"J Exp Med"},{"key":"key20200713231822_b21-mmr-19-03-1622","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1124\/mol.117.110593","article-title":"Leflunomide increases hepatic exposure to methotrexate and its metabolite by differentially regulating multidrug resistance-associated protein Mrp2\/3\/4 transporters via peroxisome proliferator-activated receptor \u03b1 activation","volume":"93","author":"Wang","year":"2018","journal-title":"Mol Pharmacol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:01:39Z","timestamp":1594684899000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2019.9821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":21,"URL":"https:\/\/doi.org\/10.3892\/mmr.2019.9821","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]}}}